Instil Bio’s stock surged over 25% on Tuesday to levels last seen in early December after Jefferies upgraded the shares to ...

Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Sheila Kahyaoglu, Jefferies aerospace and defense analyst, joins CNBC's The Exchange to discuss why her firm increased the ...

Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

Jefferies analyst Brent Thill upgraded Procore (PCOR) to Buy from Hold with a price target of $100, up from $80. The firm expects a favorable ...

The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...

After Zomato’s shares more than doubled in value in 2024, analysts at Jefferies predict that 2025 could be a breather year, with the stock likely shifting gears into a phase of price consolidation.

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...